Efficacy and Tolerance of Therapeutic Apheresis in Paediatric Neurology: a French Multicenter Study

Apheresis Related Complication Clinical Trial

Official title: Efficacy and Tolerance of Therapeutic Apheresis in Paediatric Neurology: a Retrospective French Multicenter Study

Status Completed

Clinical Trial Summary

After developing in pediatric hematology and nephrology, therapeutic apheresis is increasingly used in pediatric neurology despite a sparse level of evidence.

There are a few retrospective series with a small number of patients, concerning mainly autoimmune diseases (encephalitis, myasthenia gravis, polyradiculoneuritis).

The objective of this work is to study therapeutic apheresis (including plasma exchange and immunoadsorption) among french neuropediatric tertiary centers and to prove that this treatment modality is effective and well tolerated in pediatric neurology diseases.

Clinical Trial Description

Multicenter medical data collection :

• Montpellier

• Toulouse

• Bordeaux

• Marseille

• Nancy

• Paris Kremlin Bicêtre

• Paris Robert Debré

• Paris Necker

• Paris Trousseau

• Lyon

• Besançon

• Rennes

• Reims

• Strasbourg

• La Réunion

• Nantes

• Tours ;

Related Conditions & MeSH terms

• Apheresis Related Complication

• NCT number: NCT04845516
• Study type: Observational
• Source: University Hospital, Montpellier
• Status: Completed
• Start date: February 15, 2021
• Completion date: December 31, 2021